Serotype transmission dynamics and reduced incidence of invasive pneumococcal disease caused by different serotypes after implementation of non-pharmaceutical interventions during COVID-19 pandemic

Eur Respir J. 2021 Nov 4;58(5):2100978. doi: 10.1183/13993003.00978-2021. Print 2021 Oct.

Abstract

Significant reduction in the incidence rates of both vaccine and non-vaccine serotype invasive pneumococcal disease among children and adults during the COVID-19 pandemic were observed after the implementation of non-pharmaceutical interventions https://bit.ly/36CAute

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Humans
  • Incidence
  • Infant
  • Pandemics / prevention & control
  • Pneumococcal Infections* / epidemiology
  • Pneumococcal Infections* / prevention & control
  • Pneumococcal Vaccines
  • SARS-CoV-2
  • Serogroup
  • Serotyping

Substances

  • Pneumococcal Vaccines